Optimi Health CEO Dane Stevens buys 18,700 shares in mid-July trades
The purchases, made indirectly through a controlled company, lifted Stevens' beneficial holdings to 452,547 shares.
Optimi Health Corp. disclosed in a Form 6-K filing dated July 20, 2026 that Chief Executive Officer Dane Stevens made open market purchases of 18,700 common shares of Optimi Health Corp.1
The transactions were not made directly by Stevens. The purchases were made indirectly through Cathay Visions Enterprises Ltd., a company controlled by Mr. Stevens.1
The buying took place over two consecutive trading days. The purchases occurred on July 15 and 16, 2026, with 15,000 shares bought at US$4.4940, 3,000 shares at CDN$6.9496 and 700 shares at CDN$6.9271.1 In aggregate, Mr. Stevens indirectly acquired 18,700 common shares over the two trading days.1
Following the transactions, Stevens' total stake in the company grew. Following these transactions, Mr. Stevens beneficially holds 452,547 common shares of Optimi Health Corp.1
The filing was submitted as a Report of Foreign Private Issuer under the Securities Exchange Act of 1934, with the exhibit described as a SEDI Report Statement1. Optimi Health Corp. is based in Princeton, B.C., Canada, and trades on Nasdaq under the ticker OPTH. The report was signed by Dane Stevens, listed as Chief Executive Officer, Chief Marketing Officer and Director1, on July 20, 2026.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.